TITLE

Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection

AUTHOR(S)
Zarychanski, Ryan; Stuart, Tammy L.; Kumar, Anand; Doucette, Steve; Elliott, Lawrence; Kettner, Joel; Plummer, Frank
PUB. DATE
February 2010
SOURCE
CMAJ: Canadian Medical Association Journal;2/23/2010, Vol. 182 Issue 3, p257
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: In the context of 2009 pandemic influenza (H1N1) virus infection (pandemic H1N1 influenza), identifying correlates of the severity of disease is critical to guiding the implementation of antiviral strategies, prioritization of vaccination efforts and planning of health infrastructure. The objective of this study was to identify factors correlated with severity of disease in confirmed cases of pandemic H1N1 influenza. Methods: This cumulative case-control study included all laboratory-confirmed cases of pandemic H1N1 influenza among residents of the province of Manitoba, Canada, for whom the final location of treatment was known. Severe cases were defined by admission to a provincial intensive care unit (ICU). Factors associated with severe disease necessitating admission to the ICU were determined by comparing ICU cases with two control groups: patients who were admitted to hospital but not to an ICU and those who remained in the community. Results: As of Sept. 5, 2009, there had been 795 confirmed cases of pandemic H1N1 influenza in Manitoba for which the final treatment location could be determined. The mean age of individuals with laboratory-confirmed infection was 25.3 (standard deviation 18.8) years. More than half of the patients (417 or 52%) were female, and 215 (37%) of 588 confirmed infections for which ethnicity was known occurred in First Nations residents. The proportion of First Nations residents increased with increasing severity of disease (116 [28%] of 410 community cases, 74 [54%] of 136 admitted to hospital and 25 [60%] of 42 admitted to an ICU; p < 0.001), as did the presence of an underlying comorbidity (201 [35%] of 569 community cases, 103 [57%] of 181 admitted to hospital and 34 [76%] of 45 admitted to an ICU; p < 0.001). The median interval from onset of symptoms to initiation of antiviral therapy was 2 days (interquartile range, IQR 1-3) for community cases, 4 days (IQR 2-6) for patients admitted to hospital and 6 days (IQR 4-9) for those admitted to an ICU (p < 0.001). In a multivariable logistic model, the interval from onset of symptoms to initiation of antiviral therapy (odds ratio [OR] 8.24, 95% confidence interval [CI] 2.82-24.1), First Nations ethnicity (OR 6.52, 95% CI 2.04-20.8) and presence of an underlying comorbidity (OR 3.19, 95% CI 1.07-9.52) were associated with increased odds of admission to the ICU (i.e., severe disease) relative to community cases. In an analysis of ICU cases compared with patients admitted to hospital, First Nations ethnicity (OR 3.23, 95% CI 1.04-10.1) was associated with increased severity of disease. Interpretation: Severe pandemic H1N1 influenza necessitating admission to the ICU was associated with a longer interval from onset of symptoms to treatment with antiviral therapy and with the presence of an underlying comorbidity. First Nations ethnicity appeared to be an independent determinant of severe infection. Despite these associations, the cause and outcomes of pandemic HINI influenza may involve many complex and interrelated factors, all of which require further research and analysis.
ACCESSION #
48490003

 

Related Articles

  • Effect of Vaccines and Antivirals during the Major 2009 A(H1N1) Pandemic Wave in Norway - And the Influence of Vaccination Timing. de Blasio, Birgitte Freiesleben; Iversen, Bj�rn G.; Tomba, Gianpaolo Scalia // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    To evaluate the impact of mass vaccination with adjuvanted vaccines (eventually 40% population coverage) and antivirals during the 2009 influenza pandemic in Norway, we fitted an age-structured SEIR model using data on vaccinations and sales of antivirals in 2009/10 in Norway to Norwegian ILI...

  • Effect of Vaccines and Antivirals during the Major 2009 A(H1N1) Pandemic Wave in Norway - And the Influence of Vaccination Timing. de Blasio, Birgitte Freiesleben; Iversen, Bjørn G.; Tomba, Gianpaolo Scalia // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    To evaluate the impact of mass vaccination with adjuvanted vaccines (eventually 40% population coverage) and antivirals during the 2009 influenza pandemic in Norway, we fitted an age-structured SEIR model using data on vaccinations and sales of antivirals in 2009/10 in Norway to Norwegian ILI...

  • Public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios. Rubinstein, Helena; Marcu, Afrodita; Yardley, Lucy; Michie, Susan // BMC Public Health;2015, Vol. 15 Issue 1, p1 

    Background: During the 2009-2010 A(H1N1) pandemic, many people did not seek care quickly enough, failed to take a full course of antivirals despite being authorised to receive them, and were not vaccinated. Understanding facilitators and barriers to the uptake of vaccination and antiviral...

  • Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. Campbell, Alexia; Rodin, Rachel; Kropp, Rhonda; Yang Mao; Zhiyong Hong; Vachon, Julie; Spika, John; Pelletier, Louise // CMAJ: Canadian Medical Association Journal;3/9/2010, Vol. 182 Issue 4, p349 

    Background: We describe the disease characteristics and outcomes, including risk factors for admission to intensive care unit (ICU) and death, of all patients in Canada admitted to hospital with pandemic (H1N1) influenza during the first five months of the pandemic. Methods: We obtained data for...

  • When should a diagnosis of influenza be considered in adults requiring intensive care unit admission? Results of population-based active surveillance in Toronto. Kuster, Stefan P.; Katz, Kevin C.; Blair, Joanne; Downey, James; J.^Drews, Steven; Finkelstein, Sandy; Fowler, Rob; Green, Karen; Gubbay, Jonathan; Hassan, Kazi; Lapinsky, Stephen E.; Mazzulli, Tony; McRitchie, Donna; Pataki, Janos; Plevneshi, Agron; Powis, Jeff; Rose, David; Sarabia, Alicia; Simone, Carmine; Simor, Andrew // Critical Care;2011, Vol. 15 Issue 4, p1 

    Introduction: There is a paucity of data about the clinical characteristics that help identify patients at high risk of influenza infection upon ICU admission. We aimed to identify predictors of influenza infection in patients admitted to ICUs during the 2007/2008 and 2008/2009 influenza seasons...

  • Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A. Rodríguez, Alejandro; Díaz, Emili; Martí-Loeches, Ignacio; Sandiumenge, Alberto; Canadell, Laura; Díaz, Juan J.; Figueira, Juan C.; Marques, Asunción; Lvarez-Lerma, Francisco Á; Vallés, Jordi; Baladín, Bárbara; García-López, Fernando; Suberviola, Borja; Zaragoza, Rafael; Trefler, Sandra; Bonastre, Juan; Blanquer, José; Rello, Jordi // Journal of Antimicrobial Chemotherapy (JAC);May2011, Vol. 66 Issue 5, p1140 

    Objectives The impact of oseltamivir on mortality in critically ill patients with 2009 pandemic influenza A (2009 H1N1) is not clear. The main objective of this study was to investigate the relationship between the timing of antiviral administration and intensive care unit (ICU) outcomes....

  • The utility of procalcitonin in diagnosis of H1N1 influenza in intensive care patients. HAMMOND, N. E.; CORLEY, A.; FRASER, J. F. // Anaesthesia & Intensive Care;Mar2011, Vol. 39 Issue 2, p238 

    The article presents the retrospective single centre case series study to determine the utility of procalcitonin (PCT) assay in diagnosing H1N1 influenza in patients confined in the intensive care units (ICUs). The study was conducted in Queensland, Australia. In the study, a Wilcoxon rank sum...

  • H1N1 takes significant toll.  // Australian Nursing Journal;Nov2009, Vol. 17 Issue 5, p10 

    This article deals a study which examined the impact of the pandemic H1N1 influenza A virus on health care staff in critical care areas in Australia and New Zealand. According to the study, one in five intensive care unit beds were occupied by patients with H1N1 influenza A infection. It notes...

  • Severe Pneumonia Associated with Pandemic (H1N1) 2009 Outbreak, San Luis Potosí, Mexico. Gómez-Gómez, Alejandro; Magaña-Aquino, Martin; García-Sepúlveda, Christian A.; Ochoa-Pérez, Uciel R.; Falcón-Escobedo, Reynaldo; Comas-García, Andreu; Aranda-Romo, Saray; Contreras-Treviño, Hugo I.; Jiménez-Rico, Paulina V.; Banda-Barbosa, Mario A.; Dominguez-Paulin, Félix; Bernal-Blanco, J. Mario; Pérez-González, Luis F.; Noyola, Daniel E. // Emerging Infectious Diseases;Jan2010, Vol. 16 Issue 1, p27 

    We describe the clinical characteristics and outcomes of adults hospitalized with pneumonia during the pandemic (H1N1) 2009 outbreak. Patients admitted to a general hospital in San Luis Potosí, Mexico, from April 10 through May 11, 2009, suspected to have influenza virus--associated pneumonia...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics